REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmasys Private Limited (India)

Main Activities: Artificial and Synthetic Fibers and Filaments Manufacturing
Full name: Pharmasys Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pharmasys Private Limited is based in India, with the head office in North Delhi. The enterprise currently operates in the Artificial and Synthetic Fibers and Filaments Manufacturing sector. It was established on June 06, 2019. It currently has a total number of 7 (2025) employees. From the latest financial highlights, Pharmasys Private Limited reported a net sales revenue increase of 1.15% in 2025. Over the same period, its total assets grew by 31.31%. The net profit margin of Pharmasys Private Limited increased by 2.93% in 2025.

Legal Address
Plot No-6, 1St Floor, Lsc Pocket-5, Sector A-10, Opp. Sports Complex Narela
North Delhi; Delhi; Postal Code: 110040

Contact Details: Purchase the Pharmasys Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Pharmasys Private Limited report to view the information.
Registered Capital:
Purchase the Pharmasys Private Limited report to view the information.
Financial Auditors:
Purchase the Pharmasys Private Limited report to view the information.
Incorporation Date:
June 06, 2019
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Pharmasys Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
1.15%
Total Operating Revenue
5.91%
Operating Profit
17.9%
EBITDA
18.15%
Net Profit/Loss for the Period
14.86%
Total Assets
31.31%
Total Equity
32.3%
Operating Profit Margin
4.92%
Net Profit Margin
2.93%
Return on Equity (ROE)
-3.7%
Debt / Equity
6.28%
Quick Ratio
-0.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?